{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:35:39Z","timestamp":1793424939302,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circ: Cardiovascular Quality and Outcomes"],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Mobile health technologies are low cost, scalable interventions with the potential to promote patient engagement and behavior change. We aimed to test whether a culturally sensitive text messaging intervention supporting secondary prevention improves the control of risk factors in patients with coronary heart disease in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results:<\/jats:title>\n                    <jats:p>\n                      In this multicenter, single-blinded randomized controlled trial, 822 patients (mean age, 56.4 [SD, 9.5] years; 14.1% women) with coronary heart disease and without diabetes mellitus from 37 hospitals in China were enrolled between August 2016 and March 2017. In addition to usual care, the control group (n=411) received 2 thank you messages\/month; the intervention group (n=411) received 6 text messages\/week for 6 months delivered by an automated computerized system. The messages provided educational and motivational information related to disease-specific knowledge, risk factor control, physical activity, and medication adherence. The primary end point was change in systolic blood pressure from baseline to 6 months. Secondary end points included the proportion with systolic blood pressure &lt;140 mm\u2009Hg, smoking status, and change in body mass index, LDL-C (low-density lipoprotein cholesterol), and physical activity (assessed using the International Physical Activity Questionnaire). The end points were assessed using analyses of covariance. Follow-up was 99.6%. At 6 months, systolic blood pressure was not significantly lower in the intervention group compared with the control group, with a mean change (SD) of 3.2 (14.3) mm\u2009Hg and 2.0 (15.0) mm\u2009Hg (\n                      <jats:italic>P<\/jats:italic>\n                      &gt;0.05) from baseline, respectively (mean net change, \u22121.3 mm\u2009Hg [95% CI, \u22123.3 to 0.8];\n                      <jats:italic>P<\/jats:italic>\n                      =0.221). There were no significant differences in the change in LDL-C level, physical activity, body mass index, or smoking status between the 2 groups. Nearly all patients in the intervention group reported the text messages to be useful (96.1%), easy to understand (98.8%), appropriate in frequency (93.8%), and reported being willing to receive future text messages (94.8%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Text messages supporting secondary prevention among patients with coronary heart disease did not lead to a greater reduction in blood pressure at 6 months. Mobile phone text messaging for secondary prevention was feasible and highly acceptable to patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Registration:<\/jats:title>\n                    <jats:p>\n                      URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\">https:\/\/clinicaltrials.gov<\/jats:ext-link>\n                      . Unique identifier: NCT02888769.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/circoutcomes.119.005616","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T14:00:17Z","timestamp":1554559217000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":63,"title":["Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease"],"prefix":"10.1161","volume":"12","author":[{"given":"Xin","family":"Zheng","sequence":"first","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Spatz","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT (E.S.S., Q.D., H.M.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Bai","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqian","family":"Huo","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglan","family":"Ding","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT (E.S.S., Q.D., H.M.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Horak","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, CA (P.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuekun","family":"Wu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchi","family":"Guan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara K.","family":"Chow","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre, Faculty of Medicine and Health, University of Sydney and The George Institute for Global Health, Australia (C.K.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Yan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Wang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Liu","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (X.Z., X.B., X.H., X.W., W.G., X.Y., Y.S., X.W., H.Z., J. Liu, J. Li., X.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[{"name":"Health Outcomes Research, Saint Luke\u2019s Mid America Heart Institute\/University of Missouri-Kansas City, Kansas City, MO (J.A.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Masoudi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora (F.A.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlan M.","family":"Krumholz","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT (E.S.S., Q.D., H.M.K.)."},{"name":"Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine and the Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61097-1"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00551-6"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311890"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61699-7"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61696-1"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60921-1"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.0166"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60783-6"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.03.033"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm4030412"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.07.001"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-1173"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017530"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10945"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69252-0"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.250"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-018302"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.172596"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26461"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.114.000967"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-004-0612-6"},{"key":"e_1_3_4_23_2","first-page":"579","article-title":"[2010 Chinese guidelines for the management of hypertension].","volume":"39","author":"Liu LS","year":"2011","unstructured":"Liu, LS; Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579\u2013615.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"e_1_3_4_24_2","first-page":"1101","article-title":"Chinese guidelines for blood pressure measurement.","volume":"6","author":"Wang W","year":"2011","unstructured":"Wang, W, Weizhong, Z, Ninglin, S. Chinese guidelines for blood pressure measurement. Chinese Journal of Hypertension. 2011;6:1101\u20131115.","journal-title":"Chinese Journal of Hypertension"},{"key":"e_1_3_4_25_2","unstructured":"Group I. International physical activity questionnaire. 2002; Available at: https:\/\/sites.google.com\/site\/theipaq\/home. Accessed Jan 27 2019."},{"key":"e_1_3_4_26_2","first-page":"265","article-title":"Study on the reliability and validity of international physical activity questionnaire(Chinese vision,IPAQ).","volume":"25","author":"Qu NN","year":"2004","unstructured":"Qu, NN, Li, KJ. Study on the reliability and validity of international physical activity questionnaire(Chinese vision,IPAQ). Chin J Epidemiol. 2004;25:265\u2013268.","journal-title":"Chin J Epidemiol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/13557858.2016.1263289"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00381-2"},{"key":"e_1_3_4_29_2","unstructured":"Yu X Han H Du J Wei L Li C Zhang X Li H Huang Y Sun K Li N West D Bleiberg J. mHealth in China and the United States: How Mobile Technology is Transforming Healthcare in the World\u2019s Two Largest Economies. Center of Technology Innovations at Brookings. 2013. Available at: https:\/\/www.issuelab.org\/resource\/mhealth-in-china-and-the-united-states-how-mobile-technology-is-transforming-healthcare-in-the-world-s-two-largest-economies.html. Accessed March 13 2019."},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32478-9"}],"container-title":["Circulation: Cardiovascular Quality and Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCOUTCOMES.119.005616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T23:35:41Z","timestamp":1715556941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCOUTCOMES.119.005616"}},"subtitle":["The CHAT Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1161\/CIRCOUTCOMES.119.005616"],"URL":"https:\/\/doi.org\/10.1161\/circoutcomes.119.005616","relation":{},"ISSN":["1941-7713","1941-7705"],"issn-type":[{"value":"1941-7713","type":"print"},{"value":"1941-7705","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"2019-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e005616"}}